Drug Shortage Report for DRAXIMAGE MDP-25

Last updated on 2023-01-04 History
Report ID 173415
Drug Identification Number 02329239
Brand name DRAXIMAGE MDP-25
Common or Proper name DRAXIMAGE MDP-25
Company Name JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA
Market Status MARKETED
Active Ingredient(s) MEDRONIC ACID
Strength(s) 25MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10X10ML
ATC code V09BA
ATC description
Reason for shortage Other (Please describe in comments)
Anticipated start date 2022-11-03
Actual start date 2022-11-03
Estimated end date 2022-12-21
Actual end date 2022-12-21
Shortage status Resolved
Updated date 2023-01-04
Company comments Delay in release of recent manufactured batches. This shortage should not have an impact on patients since Jubilant also manufactures Draximage MDP 10 mg/vial (DIN 02329409) that is commercially available and can be used alternatively.
Health Canada comments
Tier 3 Status No
Contact Address 16751 TRANS CANADA HWY
KIRKLAND, QUEBEC
CANADA H9H 4J4
Company contact information Hiba Soulaihi HSoulaihi@jubl.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2023-01-04 French Compare
v15 2023-01-04 French Compare
v14 2023-01-04 English Compare
v13 2022-11-29 French Compare
v12 2022-11-29 English Compare
v11 2022-11-29 English Compare
v10 2022-11-04 English Compare
v9 2022-11-03 French Compare
v8 2022-11-03 English Compare
v7 2022-11-03 French Compare
v6 2022-11-03 French Compare
v4 2022-11-03 English Compare
v5 2022-11-03 English Compare
v3 2022-11-03 French Compare
v2 2022-11-03 English Compare
v1 2022-11-03 English Compare

Showing 1 to 16 of 16